United Biomedical Inc - Apr 25, 2022 Form 4 Insider Report for Vaxxinity, Inc. (VAXX)

Role
10%+ Owner
Signature
/s/ Mei Mei Hu, As Director and Officer
Stock symbol
VAXX
Transactions as of
Apr 25, 2022
Transactions value $
$27,073
Form type
4
Date filed
4/27/2022, 08:36 PM
Previous filing
Nov 15, 2021
Next filing
Apr 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VAXX Class A common stock Purchase $27.1K +8.04K +0.16% $3.37 5.19M Apr 25, 2022 Direct F1, F2
holding VAXX Class A common stock 4.21M Apr 25, 2022 Held by United Biomedical Inc., Asia F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported is a weighted average price.
F3 Held by United Biomedical, Asia Inc. ("UBIA"). The Reporting Person, through a subsidiary, holds a majority equity interest in UBIA and may be deemed to be the beneficial owner of the shares held by UBIA. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by UBIA in which the Reporting Person has no pecuniary interest.